DEFA14A: AlphaVest Faces Imminent Nasdaq Delisting Risk

AlphaVest Acquisition Corp. filed a proxy statement supplement detailing an increased risk of Nasdaq delisting if it fails to complete a business combination by December 22, 2025.

Summary

• AlphaVest Acquisition Corp. (AlphaVest) filed a supplement to its definitive proxy statement for an Extraordinary General Meeting scheduled for September 19, 2025.
• The supplement amends and restates a key risk factor concerning the potential delisting of AlphaVest's securities from Nasdaq.
• Nasdaq Rule IM-5101-2 requires SPACs to complete a business combination within 36 months of their initial public offering (IPO) effectiveness.
• AlphaVest's registration statement became effective on December 22, 2022, setting a business combination deadline of December 22, 2025.
• Failure to meet the December 22, 2025, deadline will result in a Nasdaq Staff Delisting Determination, even though an Extension Amendment Proposal allows for extensions up to January 22, 2026.
• Significant shareholder redemptions in connection with the Extension Proposal could also lead to the company failing Nasdaq's continued listing requirements.

Sentiment

Score: 3

Explanation: The filing explicitly details a significant and imminent risk of delisting from Nasdaq, which would severely impact the company's operations, liquidity, and ability to complete a business combination. This is a clear negative development that increases uncertainty and downside risk for investors.

Negatives

• Potential delisting from Nasdaq, leading to limited market quotations, reduced liquidity, and decreased demand for securities.
• Ordinary Shares may be classified as 'penny stock' (price less than $5.00), subjecting brokers to more stringent rules and further reducing trading activity.
• The company may be deemed a less attractive merger partner, decreasing the likelihood of consummating a business combination.
• Securityholders may have a decreased ability to trade securities if they are no longer considered 'covered securities' under federal law.
• Loss of 'covered securities' status would subject the company to state-level regulation for securities sales, making business combinations more difficult and costly.
• Securityholders could be prohibited from trading in their securities if the company is not registered in their state, which AlphaVest currently does not plan to do.
• Limited news and analyst coverage, and a decreased ability to issue additional securities or obtain future financing.

Risks

• Nasdaq may delist securities if the company fails to meet continued listing requirements, particularly if public shareholders exercise significant redemption rights.
• Failure to complete an initial business combination by December 22, 2025, will result in a Nasdaq Staff Delisting Determination under Rule 5810, leading to immediate suspension and delisting.
• Even if an Extension Amendment Proposal is approved, allowing extensions up to January 22, 2026, the Nasdaq rule's December 22, 2025, deadline for business combination completion remains a critical delisting trigger.
• Delisting could lead to securities being quoted on an over-the-counter market, resulting in reduced liquidity, demand, and market quotations.
• Ordinary Shares could become subject to 'penny stock' regulations, imposing stricter broker-dealer requirements and potentially reducing secondary market trading activity.
• Loss of 'covered securities' status would subject the company to state securities regulations, increasing the complexity and cost of completing a business combination and potentially restricting securityholder trading.

Future Outlook

The company faces an imminent risk of Nasdaq delisting if it fails to complete a business combination by December 22, 2025, despite a potential extension proposal. If delisted, securities are expected to be quoted on an over-the-counter market, leading to reduced liquidity and potentially making the company a less attractive merger partner. The company does not currently plan to register its securities in any state, which could further restrict trading for securityholders if delisted.

Industry Context

This filing highlights a common and critical challenge for Special Purpose Acquisition Companies (SPACs) as they approach their mandated deadline for completing a business combination. The risk of delisting due to failure to merge or significant shareholder redemptions is a prevalent concern in the SPAC industry, impacting investor confidence and the viability of these vehicles.

Corporate Governance

Stakeholder Impact

• Shareholders face reduced liquidity, potential 'penny stock' classification, and difficulty trading securities if delisted, including potential state-level trading prohibitions.
• Potential target companies may view AlphaVest as a less attractive merger partner due to the delisting risk and associated operational challenges.
• Brokers and dealers will face more stringent rules for transactions if the company's shares become 'penny stocks', potentially reducing trading activity.

Next Steps

• Hold the Extraordinary General Meeting on September 19, 2025, to vote on proposals, including the Extension Proposal.
• Complete an initial business combination by December 22, 2025, to avoid Nasdaq delisting.

Key Dates

Recommendation

The heightened and clarified risk of Nasdaq delisting, coupled with the imminent deadline for a business combination and the severe consequences of delisting (reduced liquidity, penny stock status, difficulty completing a merger, state-level regulatory hurdles), presents a significant downside risk for investors. The company's ability to execute its core SPAC function (finding a target) is severely jeopardized, making the stock highly speculative and prone to significant value erosion. Investors should consider exiting their positions to mitigate potential losses.

Keywords

AlphaVest Acquisition Corp, SPAC, Nasdaq, delisting, business combination, proxy statement, redemption rights, penny stock, SEC filing, corporate governance